Auracast platform expansion underway with Clinico Inc
Filed with ASX · · 4 pages · English
Summary by 6ix AI
Audeara Ltd. has announced the expansion of its Auracast platform through new commercial programs with Clinico Inc., marking the start of three white-label initiatives. The announcement highlights the ongoing strategy to scale Audeara's technology division and the potential for significant revenue growth through established partnerships.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Audeara
- Appendix 4D & Half-Year Financial Report to 31 December 2025
- Q2 FY26 Quarterly Activities Report & Appendix 4C
- December Trading Update
- NMPA secured for China Hearing Aid Launch
- $1.22m R&D Tax Incentive received
Later from Audeara
- Q3 FY26 Quarterly Activities Report & Appendix 4C
- Audeara Secures Exclusive Deal with Shokz Health Global
- Q4 FY26 Quarterly Activities Report & Appendix 4C
- Chip-level AI Licensing Partnership Commercial Production
- Firm commitments of $1.26m received via Placement
Follow Audeara into a list and get an email when it puts out news.
Follow Audeara